Small molecule modulation of Smoothened activity
AUTOR(ES)
Chen, James K.
FONTE
National Academy of Sciences
RESUMO
Smoothened (Smo), a distant relative of G protein-coupled receptors, mediates Hedgehog (Hh) signaling during embryonic development and can initiate or transmit ligand-independent pathway activation in tumorigenesis. Although the cellular mechanisms that regulate Smo function remain unclear, the direct inhibition of Smo by cyclopamine, a plant-derived steroidal alkaloid, suggests that endogenous small molecules may be involved. Here we demonstrate that SAG, a chlorobenzothiophene-containing Hh pathway agonist, binds to the Smo heptahelical bundle in a manner that antagonizes cyclopamine action. In addition, we have identified four small molecules that directly inhibit Smo activity but are structurally distinct from cyclopamine. Functional and biochemical studies of these compounds provide evidence for the small molecule modulation of Smo through multiple mechanisms and yield insights into the physiological regulation of Smo activity. The mechanistic differences between the Smo antagonists may be useful in the therapeutic manipulation of Hh signaling.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=137838Documentos Relacionados
- Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists
- Converse Conformational Control of Smoothened Activity by Structurally Related Small Molecules*
- Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces
- A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity
- Bypassing Kinase Activity of the Tomato Pto Resistance Protein with Small Molecule Ligands*S⃞